167 related articles for article (PubMed ID: 29353763)
1. The Metacognitions about Gambling Questionnaire: Development and psychometric properties.
Caselli G; Fernie B; Canfora F; Mascolo C; Ferrari A; Antonioni M; Giustina L; Donato G; Marcotriggiani A; Bertani A; Altieri A; Pellegrini E; Spada MM
Psychiatry Res; 2018 Mar; 261():367-374. PubMed ID: 29353763
[TBL] [Abstract][Full Text] [Related]
2. The Metacognitions about Online Gaming Scale: Development and psychometric properties.
Spada MM; Caselli G
Addict Behav; 2017 Jan; 64():281-286. PubMed ID: 26210288
[TBL] [Abstract][Full Text] [Related]
3. The Metacognitions about Smoking Questionnaire: development and psychometric properties.
Nikčević AV; Caselli G; Wells A; Spada MM
Addict Behav; 2015 May; 44():102-107. PubMed ID: 25467857
[TBL] [Abstract][Full Text] [Related]
4. Metacognitions about problematic Smartphone use: Development of a self-report measure.
Casale S; Caponi L; Fioravanti G
Addict Behav; 2020 Oct; 109():106484. PubMed ID: 32497956
[TBL] [Abstract][Full Text] [Related]
5. The Metacognitions about Desire Thinking Questionnaire: development and psychometric properties.
Caselli G; Spada MM
J Clin Psychol; 2013 Dec; 69(12):1284-98. PubMed ID: 23794387
[TBL] [Abstract][Full Text] [Related]
6. Metacognitions in smoking: Evidence from a cross-cultural validation of the metacognitions about smoking questionnaire in a Turkish sample.
Alma L; Spada MM; Fernie BA; Yilmaz-Samanci AE; Caselli G; Nikčević AV
Psychiatry Res; 2018 Jan; 259():160-168. PubMed ID: 29053986
[TBL] [Abstract][Full Text] [Related]
7. Psychometric properties of the Metacognitions about Smartphone Use Questionnaire (MSUQ) in a sample of iranians.
Akbari M; Zamani E; Fioravanti G; Casale S
Addict Behav; 2021 Mar; 114():106722. PubMed ID: 33160750
[TBL] [Abstract][Full Text] [Related]
8. The Metacognitions about Symptoms Control Scale: Development and Concurrent Validity.
Fernie BA; Maher-Edwards L; Murphy G; Nikčević AV; Spada MM
Clin Psychol Psychother; 2015; 22(5):443-9. PubMed ID: 24899521
[TBL] [Abstract][Full Text] [Related]
9. [Psychometric approach of metacognition: Pilot study in clinical population].
Visinet A; Soumet-Leman C; Baptista A; Bungener C; Jouvent R
Encephale; 2017 Apr; 43(2):120-127. PubMed ID: 27349578
[TBL] [Abstract][Full Text] [Related]
10. Metacognitions as a predictor of online gaming in adolescents: Psychometric properties of the metacognitions about online gaming scale among Iranian adolescents.
Akbari M; Bahadori MH; Bouruki Milan B; Caselli G; Spada MM
Addict Behav; 2021 Jul; 118():106904. PubMed ID: 33743493
[TBL] [Abstract][Full Text] [Related]
11. The psychometric properties of the Persian version of the metacognitions about Smoking Questionnaire among smokers.
Najafi M; Khosravani V; Shahhosseini M; Afshari A
Addict Behav; 2018 Sep; 84():62-68. PubMed ID: 29627635
[TBL] [Abstract][Full Text] [Related]
12. Psychometric properties of the metacognitions about smartphone use questionnaire (MSUQ) in Chinese college students.
Shi Z; Chen H; Guan J; Xie Y; Huang S; Chen X; Liu B; Shu Y
Addict Behav; 2021 Dec; 123():107041. PubMed ID: 34359017
[TBL] [Abstract][Full Text] [Related]
13. Psychometric properties of the Persian versions of the Positive Alcohol Metacognitions Scale (Persian-PAMS) and the Negative Alcohol Metacognitions Scale (Persian-NAMS) in alcohol-dependent individuals.
Khosravani V; Zandifar A; Sharifi Bastan F; Kolubinski DC; Amirinezhad A
Addict Behav; 2020 Feb; 101():106113. PubMed ID: 31648141
[TBL] [Abstract][Full Text] [Related]
14. Examining psychometric properties of the Metacognitions about Smoking Questionnaire among young e-cigarette users.
Sumbe A; Suchting R; Chen B; Wilkinson AV; Bataineh B; Clendennen SL; Harrell MB
Addict Behav; 2024 Mar; 150():107913. PubMed ID: 37992452
[TBL] [Abstract][Full Text] [Related]
15. The Metacognitions about Binge Eating Questionnaire: Investigation of the association between specific metacognitions and Binge Eating Disorder.
Palmieri S; Mansueto G; Marchant AP; Sassaroli S; Caselli G; Ruggiero GM; Spada MM
Clin Psychol Psychother; 2023; 30(4):780-794. PubMed ID: 36754777
[TBL] [Abstract][Full Text] [Related]
16. Transcultural, transdiagnostic, and concurrent validity of a revised metacognitions about symptoms control scale.
Fernie BA; Aoun A; Kollmann J; Spada MM; Nikčević AV
Clin Psychol Psychother; 2019 Jul; 26(4):471-482. PubMed ID: 30927302
[TBL] [Abstract][Full Text] [Related]
17. The association between metacognitions and the impact of Fibromyalgia in a German sample.
Kollmann J; Gollwitzer M; Spada MM; Fernie BA
J Psychosom Res; 2016 Apr; 83():1-9. PubMed ID: 27020069
[TBL] [Abstract][Full Text] [Related]
18. Positive and negative metacognitions about alcohol: Validity of the Norwegian PAMS and NAMS.
Janssen AG; Kennair LEO; Hagen R; Hjemdal O; Havnen A; Solem S
Addict Behav; 2020 Sep; 108():106466. PubMed ID: 32438222
[TBL] [Abstract][Full Text] [Related]
19. Metacognitions in problem gambling.
Lindberg A; Fernie BA; Spada MM
J Gambl Stud; 2011 Mar; 27(1):73-81. PubMed ID: 20429027
[TBL] [Abstract][Full Text] [Related]
20. Measuring metacognition in cancer: validation of the Metacognitions Questionnaire 30 (MCQ-30).
Cook SA; Salmon P; Dunn G; Fisher P
PLoS One; 2014; 9(9):e107302. PubMed ID: 25215527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
